{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:56:10Z","timestamp":1781279770410,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ajem.2022.05.021","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T12:02:48Z","timestamp":1653048168000},"page":"52-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Comparison of tenecteplase versus alteplase in STEMI patients treated with ticagrelor: A cross-sectional study"],"prefix":"10.1016","volume":"58","author":[{"given":"Serhat","family":"G\u00fcnl\u00fc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajem.2022.05.021_bb0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ajem.2022.05.021_bb0010","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.ajem.2022.05.021_bb0015","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.109.927582","article-title":"Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a platelet inhibition and patient outcomes (PLATO) trial subgroup analysis","volume":"122","author":"Steg","year":"2010","journal-title":"Circulation."},{"issue":"2","key":"10.1016\/j.ajem.2022.05.021_bb0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1074248413511693","article-title":"Characterization of the adenosine pharmacology of ticagrelor reveals therapeutically relevant inhibition of equilibrative nucleoside transporter 1","volume":"19","author":"Armstrong","year":"2014","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.ajem.2022.05.021_bb0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ahj.2017.07.013","article-title":"Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCI","volume":"192","author":"Dehghani","year":"2017","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.ajem.2022.05.021_bb0030","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742c84","volume":"127","author":"O\u2019Gara","year":"2013","journal-title":"Circulation."},{"issue":"15","key":"10.1016\/j.ajem.2022.05.021_bb0035","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1056\/NEJMoa1301092","article-title":"Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction","volume":"368","author":"Armstrong","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajem.2022.05.021_bb0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11239-015-1183-9","article-title":"Ticagrelor versus high dose clopidogrel in ST-segment elevation myocardial infarction patients with high platelet reactivity post fibrinolysis","volume":"40","author":"Alexopoulos","year":"2015","journal-title":"J Thromb Thrombolysis"},{"issue":"17","key":"10.1016\/j.ajem.2022.05.021_bb0045","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/eurheartj\/ehq204","article-title":"Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis","volume":"31","author":"Borgia","year":"2010","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ajem.2022.05.021_bb0050","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/eurheartj\/ehq398","article-title":"Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis","volume":"32","author":"D\u2019Souza","year":"2011","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.ajem.2022.05.021_bb0055","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.jacc.2007.07.058","article-title":"Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes","volume":"50","author":"Storey","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"37","key":"10.1016\/j.ajem.2022.05.021_bb0060","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ajem.2022.05.021_bb0065","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ahj.2009.01.003","article-title":"Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"157","author":"James","year":"2009","journal-title":"Am Heart J"},{"issue":"22","key":"10.1016\/j.ajem.2022.05.021_bb0070","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.jacc.2019.03.011","article-title":"Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis: TREAT trial","volume":"73","author":"Berwanger","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ajem.2022.05.021_bb0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11239-017-1581-2","article-title":"Long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in fibrinolytic-treated STEMI patients undergoing early PCI","volume":"45","author":"Yang","year":"2018","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"10.1016\/j.ajem.2022.05.021_bb0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/MCA.0000000000000917","article-title":"Ticagrelor versus clopidogrel in patients with ST-elevation myocardial infarction: postdischarge mild bleeding and its clinical impacts","volume":"32","author":"Song","year":"2021","journal-title":"Coron Artery Dis"},{"issue":"20","key":"10.1016\/j.ajem.2022.05.021_bb0085","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)","year":"2012","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ajem.2022.05.021_bb0090","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.5114\/aoms.2016.58929","article-title":"Safety and efficacy of tenecteplase versus alteplase in acute coronary syndrome: a systematic review and meta-analysis of randomized trials","volume":"12","author":"Guillermin","year":"2016","journal-title":"Arch Med Sci"},{"issue":"14","key":"10.1016\/j.ajem.2022.05.021_bb0095","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.4244\/EIJ-D-20-00268","article-title":"Ticagrelor versus clopidogrel in patients with STEMI treated with thrombolysis: the MIRTOS trial","volume":"16","author":"Hamilos","year":"2021","journal-title":"EuroIntervention."},{"issue":"12","key":"10.1016\/j.ajem.2022.05.021_bb0100","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.6061\/clinics\/2013(12)07","article-title":"Predictors of in-hospital mortality in patients with ST-segment elevation myocardial infarction undergoing pharmacoinvasive treatment","volume":"68","author":"Falc\u00e3o","year":"2013","journal-title":"Clinics (Sao Paulo)"},{"issue":"6","key":"10.1016\/j.ajem.2022.05.021_bb0105","first-page":"514","article-title":"An angiographic trial to evaluate the efficacy and safety of tenecteplase in Chinese patients with acute myocardial infarction","volume":"37","author":"Liang","year":"2009","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"issue":"1","key":"10.1016\/j.ajem.2022.05.021_bb0110","first-page":"e7","volume":"26","author":"So","year":"2010","journal-title":"Can J Cardiol"},{"issue":"4","key":"10.1016\/j.ajem.2022.05.021_bb0115","first-page":"373","article-title":"Efficacy and safety of switching from clopidogrel to ticagrelor at the time of discharge in STEMI patients treated with a pharmacoinvasive approach","volume":"43","author":"\u00c7oner","year":"2021","journal-title":"Erciyes Med J"},{"issue":"11","key":"10.1016\/j.ajem.2022.05.021_bb0120","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/clc.23716","article-title":"Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST-segment elevation myocardial infarction","volume":"44","author":"Welsh","year":"2021","journal-title":"Clin Cardiol"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722003187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722003187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:00:48Z","timestamp":1760025648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675722003187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":24,"alternative-id":["S0735675722003187"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2022.05.021","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of tenecteplase versus alteplase in STEMI patients treated with ticagrelor: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2022.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}